| アブストラクト | OBJECTIVE: Improving mechanisms to detect adverse drug reactions (ADRs) is key to strengthening post-marketing drug safety surveillance. Signal detection is presently unimodal, relying on a single information source. Multimodal signal detection is based on jointly analyzing multiple information sources. Building on, and expanding the work done in prior studies, the aim of the article is to further research on multimodal signal detection, explore its potential benefits, and propose methods for its construction and evaluation. MATERIAL AND METHODS: Four data sources are investigated; FDA's adverse event reporting system, insurance claims, the MEDLINE citation database, and the logs of major Web search engines. Published methods are used to generate and combine signals from each data source. Two distinct reference benchmarks corresponding to well-established and recently labeled ADRs respectively are used to evaluate the performance of multimodal signal detection in terms of area under the ROC curve (AUC) and lead-time-to-detection, with the latter relative to labeling revision dates. RESULTS: Limited to our reference benchmarks, multimodal signal detection provides AUC improvements ranging from 0.04 to 0.09 based on a widely used evaluation benchmark, and a comparative added lead-time of 7-22 months relative to labeling revision dates from a time-indexed benchmark. CONCLUSIONS: The results support the notion that utilizing and jointly analyzing multiple data sources may lead to improved signal detection. Given certain data and benchmark limitations, the early stage of development, and the complexity of ADRs, it is currently not possible to make definitive statements about the ultimate utility of the concept. Continued development of multimodal signal detection requires a deeper understanding the data sources used, additional benchmarks, and further research on methods to generate and synthesize signals. |
|---|
| ジャーナル名 | Journal of biomedical informatics |
|---|
| Pubmed追加日 | 2017/10/31 |
|---|
| 投稿者 | Harpaz, Rave; DuMouchel, William; Schuemie, Martijn; Bodenreider, Olivier; Friedman, Carol; Horvitz, Eric; Ripple, Anna; Sorbello, Alfred; White, Ryen W; Winnenburg, Rainer; Shah, Nigam H |
|---|
| 組織名 | Oracle Health Sciences, Bedford, MA, United States. Electronic address:;rave.harpaz@oracle.com.;Oracle Health Sciences, Bedford, MA, United States.;Janssen Research and Development, Titusville, NJ, United States.;National Library of Medicine, NIH, Bethesda, MD, United States.;Columbia University, New York, NY, United States.;Microsoft Research, Redmond, WA, United States.;U.S. FDA, Silver Spring, MD, United States.;Stanford University, Stanford, CA, United States. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/29081385/ |
|---|
